How cells recognize and degrade faulty mRNA.
Recognition and degradation of mRNA by nonsense-mediated decay.
This study is looking at how our cells find and get rid of faulty messages that could cause problems in making proteins, which is important for everyone’s health, and it aims to help us understand more about how our genes work and how this might relate to different diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10843095 on NIH RePORTER |
What this research studies
This research investigates the cellular mechanisms that identify and eliminate defective mRNA molecules that could lead to the production of incomplete proteins. By focusing on a process called nonsense-mediated decay (NMD), the research aims to understand how cells distinguish between normal and faulty mRNA during protein synthesis. The study employs advanced molecular techniques to analyze the interactions between mRNA and the cellular machinery responsible for its degradation. Insights gained from this research could enhance our understanding of genetic regulation and its implications for various diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders linked to nonsense mutations in their mRNA.
Not a fit: Patients with conditions unrelated to mRNA degradation or those without genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for conditions caused by faulty mRNA, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding mRNA decay mechanisms, indicating that this area of study has potential for significant advancements.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Baker, Kristian Eileen — Case Western Reserve University
- Study coordinator: Baker, Kristian Eileen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.